Communicating the risk reduction achieved by cholesterol reducing drugs
- PMID: 9641937
- PMCID: PMC1113406
- DOI: 10.1136/bmj.316.7149.1956
Communicating the risk reduction achieved by cholesterol reducing drugs
Comment in
-
Communicating risk reductions. Data were selectively used.BMJ. 1999 Feb 27;318(7183):602; author reply 603-4. BMJ. 1999. PMID: 10037654 Free PMC article. No abstract available.
-
Communicating risk reductions. One example is not enough.BMJ. 1999 Feb 27;318(7183):602-3; author reply 603-4. BMJ. 1999. PMID: 10189215 No abstract available.
References
-
- The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients: the Scandinavian simvastatin survival study (4S) Lancet. 1994;344:1383–1389. - PubMed
-
- Kjekshus J, Pedersen TR.for the Scandinavian Simvastatin Survival Study Group. Reducing the risk of coronary events: evidence from the Scandinavian simvastatin survival study (4S) Am J Cardiol 19957664–80. - PubMed
-
- Lupton D. “The great debate about cholesterol”: medical controversy and the news media. Aust NZ J Sociol. 1994;30:334–339.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources